The investment is expected to bring together Zylox-Tonbridge's peripheral vascular and neurovascular businesses with LifeTech's aortic and structural heart businesses, creating a comprehensive portfolio across four key therapeutic areas
Read MoreMedical Device Funding
The investment is expected to bring together Zylox-Tonbridge's peripheral vascular and neurovascular businesses with LifeTech's aortic and structural heart businesses, creating a comprehensive portfolio across four key therapeutic areas
Read MoreCompany's first-of-a-kind intelligent imaging system aims to expand patient access, streamline high-quality cardiac care, and establish the foundation for future robotic interventions
Read MoreProceeds will fuel BRIJ Medical's continued commercial expansion of BRIJ-SEAL™ and the upcoming launch of BRIJ-Ag™, building on strong investor confidence and growing market momentum
Read MoreSeries D proceeds to support commercialization of the Zenflow Spring® System for Men with Enlarged Prostate
Read MoreThe financing will support SedMed's next phase of commercial growth and expand access to its non-electric toilet lift, which is designed to help older adults and individuals with mobility limitations sit and stand more safely and independently while reducing strain on caregivers
Read MoreTo Advance U.S. Pivotal Trial for Novel Through-the-Scope Type 2 Diabetes Procedure
Read MoreSince launching in 2021, Angle Health has emerged as the leading alternative to traditional health insurance plans for small businesses nationwide, now serving more than 5,000 employers, offering customized health plans in 47 states, and delivering four consecutive quarters of profitability
Read MoreFirst-of-its-kind U.S. deployment of BD Vmax 160 expands pharmacy automation beyond traditional dispensing, helping health systems manage growing demand for specialty therapies, refrigerated medications, and increasingly complex fulfilment needs
Read MoreMatthew Stanton, PhD, and Leanne Peiser, DPhil, appointed CEO and CSO, respectively; former Pfizer CSO Mikael Dolsten, MD, PhD, joins Typewriter board as independent director and the Fred Hutch's Stanley R. Riddell, MD, joins Typewriter Scientific Advisory Board
Read MoreFunding led by Costanoa and joined by CVS Health Ventures and Flare Capital Partners
Read MoreThe work, led by Roswell Park’s Katerina Gurova, PhD, and Sethera CEO Karsten Eastman, PhD, could open a path toward targeted options for patients with aggressive tumors that have limited treatment choices
Read MoreInvestment supports advancement of Remedium's durable protein therapeutics platform toward first-in-human clinical development
Read More